Many investors tend to focus exclusively on investment returns with little concern for investment risk, however, is managing risk is also equally important.

Pharma major Lupin Limited, in a press release announced that it launched Testosterone Gel, on Friday. The company received USFDA approval for the same on Thursday.

It’s important for the stock to sustain and close above the neckline of the double bottom pattern which is placed in the region of Rs. 1,721-1,722. A sustainable move above the level of Rs. 1,721-1,722 is likely to open up gates for a further rally towards levels of Rs. 1,755.

Following stocks are close to their 52-weeks low as at 1.08 p.m. on April 12, 2019.

The markets on April 12, 2019 opened up. BSE Sensex is trading at 38,611.64, up by 4.63 points and the Nifty is trading at 11,594.75, down by 1.95 points. 

Leading capital good company Thermax informed the bourses that it has acquired the entire stake in its joint venture SPX Energy Technologies Limited (TSPX) on Thursday from partners namely Mutares Holding-24 AG, Germany and Balcke-Dürr GmbH, Germany.

Cipla Limited has launched Niveoli, India’s first extra-fine particle beclomethasone-formoterol combination hydrofluoroalkane (HFA) inhaler for adults, targeting drug delivery to the small airways.

The company has signed a joint venture with Jopp Holding, Germany for production and sale of auto components. Reacting to the development, the stock of Lumax Auto Technologies was up more than 2 per cent in the morning session.

Overall volumes in futures & options currently stand at 3.09 crore contracts with a turnover of Rs. 19,94,995.47 crore.

Overall volumes in futures & options currently stand at 3.09 crore contracts with a turnover of Rs. 19,94,995.47 crore.